News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
39,863 Results
Type
Article (2634)
Company Profile (39)
Press Release (37190)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (14653)
Career Advice (77)
Deals (2244)
Drug Delivery (9)
Drug Development (4261)
Employer Resources (10)
FDA (522)
Job Trends (827)
News (21007)
Policy (1129)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (154)
Allergies (6)
Alliances (3562)
ALS (4)
Alzheimer's disease (48)
Antibody-drug conjugate (ADC) (18)
Approvals (525)
Artificial intelligence (11)
Autoimmune disease (3)
Automation (1)
Bankruptcy (14)
Best Places to Work (534)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (29)
Bladder cancer (7)
Brain cancer (5)
Breast cancer (20)
Cancer (154)
Cardiovascular disease (6)
Career advice (64)
Career pathing (1)
CAR-T (16)
Cell therapy (47)
Cervical cancer (2)
Clinical research (3302)
Collaboration (94)
Compensation (52)
COVID-19 (183)
CRISPR (8)
C-suite (31)
Cystic fibrosis (7)
Data (125)
Denatured (3)
Depression (3)
Diabetes (10)
Diagnostics (481)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (15)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (4396)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6187)
Executive appointments (100)
FDA (574)
Featured Employer (3)
Funding (97)
Gene editing (15)
Gene therapy (22)
GLP-1 (64)
Government (170)
Guidances (1)
Healthcare (738)
Huntington's disease (3)
IgA nephropathy (4)
Immunology and inflammation (17)
Indications (2)
Infectious disease (188)
Inflammatory bowel disease (12)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (11)
Interviews (7)
IPO (1089)
IRA (7)
Job creations (295)
Job search strategy (62)
Kidney cancer (4)
Labor market (4)
Layoffs (40)
Leadership (1)
Legal (217)
Liver cancer (6)
Lung cancer (17)
Lymphoma (5)
Management (4)
Manufacturing (19)
MASH (5)
Medical device (321)
Medtech (321)
Mergers & acquisitions (1227)
Metabolic disorders (36)
Multiple sclerosis (8)
Neurodegenerative disease (10)
Neuropsychiatric disorders (3)
Neuroscience (96)
NextGen: Class of 2025 (391)
Non-profit (177)
Northern California (383)
Now hiring (4)
Obesity (17)
Opinion (16)
Ovarian cancer (11)
Pain (10)
Pancreatic cancer (3)
Parkinson's disease (5)
Partnered (2)
Patents (24)
Patient recruitment (5)
Peanut (1)
People (5852)
Pharmaceutical (5)
Phase I (1422)
Phase II (1648)
Phase III (883)
Pipeline (89)
Policy (12)
Postmarket research (34)
Preclinical (620)
Press Release (2)
Prostate cancer (3)
Psychedelics (2)
Radiopharmaceuticals (12)
Rare diseases (30)
Real estate (427)
Recruiting (5)
Regulatory (873)
Reports (6)
Research institute (147)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (33)
Series B (7)
Service/supplier (2)
Sickle cell disease (1)
Southern California (379)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (574)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
United States (1836)
Vaccines (28)
Venture capitalists (10)
Weight loss (13)
Women's health (1)
Worklife (1)
Date
Today (24)
Last 7 days (77)
Last 30 days (247)
Last 365 days (2660)
2025 (865)
2024 (2737)
2023 (2969)
2022 (3890)
2021 (4261)
2020 (3730)
2019 (2195)
2018 (1654)
2017 (1887)
2016 (1665)
2015 (1903)
2014 (1418)
2013 (1226)
2012 (1425)
2011 (1358)
2010 (1209)
Location
Africa (45)
Alabama (1)
Arizona (15)
Asia (2084)
Australia (308)
California (885)
Canada (141)
China (44)
Colorado (27)
Connecticut (10)
Delaware (6)
Europe (3998)
Florida (44)
Georgia (5)
Idaho (4)
Illinois (15)
India (1)
Indiana (33)
Japan (8)
Kansas (12)
Maryland (25)
Massachusetts (322)
Michigan (8)
Minnesota (15)
Missouri (3)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (72)
New York (51)
North Carolina (92)
Northern California (383)
Ohio (26)
Oklahoma (2)
Oregon (5)
Pennsylvania (56)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (379)
Tennessee (2)
Texas (73)
Utah (2)
Virginia (6)
Washington D.C. (1)
Washington State (54)
Wisconsin (6)
39,863 Results for "orbis biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Orbis Medicines Names Veteran R&D Leader Mikael Dolsten Board Chair
March 5, 2025
·
5 min read
Press Releases
Orbis Medicines Raises EUR 90 Million Series A Funding Round to Develop Pipeline of Oral Macrocycles
January 6, 2025
·
3 min read
Pharm Country
Orbis International and NIDEK Join Forces to Scale Up Artificial Intelligence Eye Screenings in Vietnam
Orbis International announces an important in-kind and financial donation from NIDEK to support Orbis’s artificial intelligence -based screening services in Vietnam.
January 16, 2024
·
4 min read
Policy
Agitated Solutions Receives Health Canada License for Orbis Microbubble Generator to Streamline Cardiac Bubble Studies
Agitated Solutions, Incorporated announced that it has been issued a Medical Device Establishment License from Health Canada for its innovative Orbis™ Microbubble Generator that simplifies and streamlines the process of saline agitation and delivery for cardiac bubble studies.
April 18, 2024
·
3 min read
Business
Novo Holdings, Forbion Lead Financing for Orbis Medicine’s $28M Seed Round
Denmark-based startup Orbis Medicines has launched with €26 million in seed funding in its drive to search for macrocycle drugs, with a focus on high-value oral alternatives to blockbuster biologics.
February 29, 2024
·
2 min read
·
Tyler Patchen
Press Releases
Junshi Biosciences Announces Toripalimab’s Approval in Singapore
March 27, 2025
·
7 min read
Business
Orbis International Teams Up with the Alcon Foundation and OMEGA to Improve Eye Care in Zambia
Global eye care nonprofit, Orbis International, is kicking off a surgical training program in Zambia on board the Orbis Flying Eye Hospital - the world’s only fully accredited ophthalmic teaching hospital on board a plane.
September 25, 2023
·
7 min read
Orbis Medicines Launches with €26 Million Seed Financing to Transform Macrocycle Drug Development through Next-Generation Orally Dosable ‘nCycles’
Orbis Medicines, a leader in oral macrocycle drug discovery, announces its launch with a €26 million financing led by global life sciences investor Novo Holdings and European life sciences venture firm Forbion.
February 29, 2024
·
6 min read
Venture Capitalists
Novo-Backed Oral Medicine Biotech Adds Lilly to Investors in $93M Series A
Orbis emerged from stealth in February 2024 with $28.1 million in seed funding. The Danish biotech, which aims to flip biologics into oral medicines, has now raised another $93 million.
January 6, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously Announced Private Placement of Approximately $300 Million
April 29, 2025
·
7 min read
1 of 3,987
Next
